CODXCo-Diagnostics, Inc.

Nasdaq codiagnostics.com


$ 1.10 $ 0.00 (0 %)    

Tuesday, 21-May-2024 15:04:18 EDT
QQQ $ 454.82 $ 0.89 (0.2 %)
DIA $ 398.57 $ 0.68 (0.17 %)
SPY $ 530.36 $ 1.30 (0.25 %)
TLT $ 91.26 $ 0.47 (0.52 %)
GLD $ 225.37 $ -0.33 (-0.15 %)
$ 1.1
$ 1.11
$ 0.00 x 0
$ 0.00 x 0
$ 1.09 - $ 1.12
$ 0.98 - $ 1.89
32,362
na
32.83M
$ -1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-28-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-25-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q1-2024-gaap-eps-031-misses-021-estimate-sales-467854k-miss-3050m-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0....

 co-diagnostics-inc-appoints-richard-abbott-as-president-concurrent-with-the-co-naming-david-nielsen-to-be-its-chief-operations-officer

Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, ...

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-25

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q4-2023-gaap-eps-050-misses-020-estimate-sales-3555m-miss-3625m-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0....

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 earnings-preview-co-diagnostics
Earnings Preview: Co-Diagnostics
03/13/2024 17:01:56

 hc-wainwright--co-reiterates-neutral-on-co-diagnostics-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Neutral and maintains $3 price target.

 co-diagnostics-announced-that-it-submitted-its-co-dx-pcr-covid-19-test-with-co-dx-pcr-pro-instrument-for-review-by-the-fda-for-emergency-use-authorization

The Company's Emergency Use Authorization submission is for the new Co-Dx PCR Pro instrument and COVID-19 test kit, designe...

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-raises-price-target-to-3

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and raises the price target fr...

 co-diagnostics-q3-2023-gaap-eps-020-beats-029-estimate-sales-246m-beat-20000k-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.29...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 biden-administration-restarts-distribution-of-free-at-home-covid-19-tests-after-suspending-for-year

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offeri...

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q2-eps-031-misses-024-estimate-sales-20000k-miss-50000k-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0....

 earnings-scheduled-for-august-10-2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION